MARKET

LENZ

LENZ

LENZ THERAPEUTICS INC
NASDAQ
16.31
-0.54
-3.20%
After Hours: 16.92 +0.61 +3.74% 18:39 01/07 EST
OPEN
17.01
PREV CLOSE
16.85
HIGH
17.51
LOW
16.11
VOLUME
1.23M
TURNOVER
--
52 WEEK HIGH
50.40
52 WEEK LOW
15.36
MARKET CAP
510.34M
P/E (TTM)
-7.7420
1D
5D
1M
3M
1Y
5Y
1D
LENZ Therapeutics Reports VIZZ Net Product Revenue Of ~ $1.6M In Q4 2025; Over 20,000 Prescriptions Filled Through Q4 2025; Rapid Uptake By Prescribing ECPs With Over 6,500 Unique Prescribing ECPs; More Than 55% Prescribed Multiple Times In Q4 2025
Benzinga · 6h ago
*LENZ Therapeutics Sees 4Q VIZZ Net Product Revenue $1.6M >LENZ
Dow Jones · 6h ago
LENZ THERAPEUTICS REPORTS FOURTH QUARTER 2025 PRELIMINARY UNAUDITED FINANCIAL RESULTS AND RECENT CORPORATE UPDATES
Reuters · 6h ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 2d ago
Lenz, Lunatus announce exclusive partnership for VIZZ in Middle East
TipRanks · 2d ago
Lenz Therapeutics Signs Exclusive Distribution Agreement for VIZZ in Middle East
Reuters · 2d ago
LENZ THERAPEUTICS AND LUNATUS ANNOUNCE EXCLUSIVE COMMERCIALIZATION PARTNERSHIP FOR VIZZ™ IN THE MIDDLE EAST
Reuters · 2d ago
Weekly Report: what happened at LENZ last week (1229-0102)?
Weekly Report · 2d ago
More
About LENZ
LENZ Therapeutics, Inc. is a pre-commercial stage biopharmaceutical company. The Company is focused on the development and commercialization of aceclidine-based eye drop to improve near vision in patients with presbyopia. The Company’s lead product candidate LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine. LNZ100 was evaluated in the registration-enabling Phase III CLARITY study as a potential therapy for the treatment of presbyopia, a condition impacting over 1.8 billion people globally and 128 million people in the United States. Its other product LNZ101, is a preservative-free eye drop containing aceclidine and brimonidine.

Webull offers Lenz Therapeutics Inc stock information, including NASDAQ: LENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LENZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LENZ stock methods without spending real money on the virtual paper trading platform.